5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.38%
Revenue growth similar to METSB.HE's 5.38%. Walter Schloss would see if both companies share industry tailwinds.
138.16%
Gross profit growth similar to METSB.HE's 138.16%. Walter Schloss would assume both firms track common industry trends.
17.40%
EBIT growth similar to METSB.HE's 17.40%. Walter Schloss might infer both firms share similar operational efficiencies.
17.40%
Operating income growth similar to METSB.HE's 17.40%. Walter Schloss would assume both share comparable operational structures.
38.46%
Net income growth comparable to METSB.HE's 38.46%. Walter Schloss might see both following similar market or cost trajectories.
50.60%
EPS growth similar to METSB.HE's 50.60%. Walter Schloss would assume both have parallel share structures and profit trends.
50.60%
Similar diluted EPS growth to METSB.HE's 50.60%. Walter Schloss might see standard sector or cyclical influences on both firms.
-8.06%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-8.06%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-53.03%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-82.66%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-30.86%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-27.50%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-5.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
454.41%
10Y OCF/share CAGR in line with METSB.HE's 454.41%. Walter Schloss would see both as similarly efficient over the decade.
-18.73%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
243.74%
3Y OCF/share CAGR similar to METSB.HE's 243.74%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
128.82%
Similar net income/share CAGR to METSB.HE's 128.82%. Walter Schloss would see parallel tailwinds or expansions for both firms.
302.67%
5Y net income/share CAGR similar to METSB.HE's 302.67%. Walter Schloss might see both on parallel mid-term trajectories.
47.12%
3Y net income/share CAGR similar to METSB.HE's 47.12%. Walter Schloss would attribute it to shared growth factors or demand patterns.
No Data
No Data available this quarter, please select a different quarter.
26.22%
5Y equity/share CAGR is in line with METSB.HE's 26.22%. Walter Schloss would see parallel mid-term profitability and retention policies.
27.90%
3Y equity/share CAGR similar to METSB.HE's 27.90%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.34%
AR growth well above METSB.HE's 8.34%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.60%
Inventory growth well above METSB.HE's 8.60%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
0.29%
Similar asset growth to METSB.HE's 0.29%. Walter Schloss finds parallel expansions or investment rates.
6.68%
Similar to METSB.HE's 6.68%. Walter Schloss finds parallel capital usage or profit distribution strategies.
5.88%
Debt growth far above METSB.HE's 5.88%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.58%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.